- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
Obesity Algorithm Challenge: 8 Questions
Test your knowledge of the newly updated obesity algorithm from the Obesity Medicine Association with this 8-question challenge.
The Obesity Medicine Association (OMA) recently released the 2018 updates to The Obesity Algorithm® for pediatric and adult patients. How much do you know about obesity trends, categories, and treatments? Find out with our 8-question quiz below.
Question 1.
Please click here for answer and next question.
Answer: B. False. Between 2015 and 2016, the prevalence of obesity was higher among US adults (40%) vs youth (18.5%).
Question 2.
Please click here for answer and next question.
Answer: D. 35-39.9. A BMI between 18.5-24.9 kg/m2 is classified as normal, 25.0-29.9 kg/m2 is classified as overweight, 30.0-34.9 kg/m2 is classified as class I obesity, 35-39.9 kg/m2 is classified as class II obesity, and ≥40 kg/m2 is classified as class III obesity.
Question 3.
Please click here for answer and next question.
Answer: D. 32%. In women, a body fat percentage of ≥32% is classified as overweight or obese.
Question 4.
Please click here for answer and next question.
Answer: B. False. DXA measures fat mass and lean soft tissue mass OR soft tissue mass and bone mineral mass, but not fat mass and soft tissue mass.
Question 5.
Please click here for answer and next question.
Answer: E. B and D. The prevalence of obesity was highest among non-Hispanic black and Hispanic adults vs non-Hispanic white and non-Hispanic Asian adults.
Question 6.
Please click here for answer and next question.
Answer: C. Orlistat. While orlistat (Alli, Xenical) is an FDA-approved anti-obesity drug, it was approved in 1999. Phentermine HCL/topiramate extended release (Qsymia) and lorcaserin (Belviq) were first approved in 2012 and liraglutide (Saxenda) was first approved in 2014.
Question 7.
Please click here for answer and next question.
Answer: A. <5000. <5000 steps taken per day is considered sedentary and this is the national average for US adults.
Question 8.
Answer: A. True. The OMA recommends that patients walk 10 minutes for every hour they have been sitting.
References:
For more information, please visit www.obesityalgorithm.org.
